Industry Research Reports
Home > Reports > Service & Software > Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
Industry: Service & Software
Published Date: 2025-09-06
Pages: 110 Pages
Report ld: 4950305
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Mammalian CDMO Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
The North America Mammalian CDMO Service market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key players of Mammalian CDMO Service include Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of revenue, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Mammalian CDMO Service market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
By Company
- Cytovance Biologics
- 3P Bio
- AGC Biologics
- KBI Biopharma
- GTP Bioways
- Tanvex CDMO
- Samsung Biologics
- WuXi Biologics
- PlantForm Corporation
- Gedeon Richter
- Lonza
- Novartis
- Rentschler Biopharma SE
- Northway Biotech
- Boehringer Ingelheim
- Cambrex
- FUJIFILM Diosynth Biotechnologies
- GBI
- Scorpius BioManufacturing
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Cell Line Development
- Genomic Analysis
- Process Development
- Analytical Services
- Formulation Development
- Manufacturing
- Others
Segment by Application
- Contract Research Organizations (CROs)
- Pharmaceutical
- Biotechnology Companies
- Government Agencies
- Others
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Mammalian CDMO Service market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Genomic Analysis in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Pharmaceutical in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Mammalian CDMO Service value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Line Development
1.2.3 Genomic Analysis
1.2.4 Process Development
1.2.5 Analytical Services
1.2.6 Formulation Development
1.2.7 Manufacturing
1.2.8 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Contract Research Organizations (CROs)
1.3.3 Pharmaceutical
1.3.4 Biotechnology Companies
1.3.5 Government Agencies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Mammalian CDMO Service Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Mammalian CDMO Service Revenue Market Share by Region (2020-2025)
2.4 Global Mammalian CDMO Service Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Mammalian CDMO Service Market Size and Prospective (2020-2031)
2.5.2 Europe Mammalian CDMO Service Market Size and Prospective (2020-2031)
2.5.3 Asia-Pacific Mammalian CDMO Service Market Size and Prospective (2020-2031)
2.5.4 Latin America Mammalian CDMO Service Market Size and Prospective (2020-2031)
2.5.5 Middle East & Africa Mammalian CDMO Service Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Mammalian CDMO Service Historic Market Size by Type (2020-2025)
3.2 Global Mammalian CDMO Service Forecasted Market Size by Type (2026-2031)
3.3 Different Types Mammalian CDMO Service Representative Players
4 Breakdown Data by Application
4.1 Global Mammalian CDMO Service Historic Market Size by Application (2020-2025)
4.2 Global Mammalian CDMO Service Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Mammalian CDMO Service Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Mammalian CDMO Service Players by Revenue (2020-2025)
5.1.2 Global Mammalian CDMO Service Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Mammalian CDMO Service Revenue
5.4 Global Mammalian CDMO Service Market Concentration Analysis
5.4.1 Global Mammalian CDMO Service Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Mammalian CDMO Service Revenue in 2024
5.5 Global Key Players of Mammalian CDMO Service Head office and Area Served
5.6 Global Key Players of Mammalian CDMO Service, Product and Application
5.7 Global Key Players of Mammalian CDMO Service, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Mammalian CDMO Service Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Mammalian CDMO Service Market Size by Type (2020-2025)
6.1.2.2 North America Mammalian CDMO Service Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Mammalian CDMO Service Market Size by Application (2020-2025)
6.1.3.2 North America Mammalian CDMO Service Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Mammalian CDMO Service Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Mammalian CDMO Service Market Size by Type (2020-2025)
6.2.2.2 Europe Mammalian CDMO Service Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Mammalian CDMO Service Market Size by Application (2020-2025)
6.2.3.2 Europe Mammalian CDMO Service Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 Asia-Pacific Market: Players, Segments and Downstream
6.3.1 Asia-Pacific Mammalian CDMO Service Revenue by Company (2020-2025)
6.3.2 Asia-Pacific Market Size by Type
6.3.2.1 Asia-Pacific Mammalian CDMO Service Market Size by Type (2020-2025)
6.3.2.2 Asia-Pacific Mammalian CDMO Service Market Share by Type (2020-2025)
6.3.3 Asia-Pacific Market Size by Application
6.3.3.1 Asia-Pacific Mammalian CDMO Service Market Size by Application (2020-2025)
6.3.3.2 Asia-Pacific Mammalian CDMO Service Market Share by Application (2020-2025)
6.3.4 Asia-Pacific Market Trend and Opportunities
6.4 Latin America Market: Players, Segments and Downstream
6.4.1 Latin America Mammalian CDMO Service Revenue by Company (2020-2025)
6.4.2 Latin America Market Size by Type
6.4.2.1 Latin America Mammalian CDMO Service Market Size by Type (2020-2025)
6.4.2.2 Latin America Mammalian CDMO Service Market Share by Type (2020-2025)
6.4.3 Latin America Market Size by Application
6.4.3.1 Latin America Mammalian CDMO Service Market Size by Application (2020-2025)
6.4.3.2 Latin America Mammalian CDMO Service Market Share by Application (2020-2025)
6.4.4 Latin America Market Trend and Opportunities
6.5 Middle East & Africa Market: Players, Segments and Downstream
6.5.1 Middle East & Africa Mammalian CDMO Service Revenue by Company (2020-2025)
6.5.2 Middle East & Africa Market Size by Type
6.5.2.1 Middle East & Africa Mammalian CDMO Service Market Size by Type (2020-2025)
6.5.2.2 Middle East & Africa Mammalian CDMO Service Market Share by Type (2020-2025)
6.5.3 Middle East & Africa Market Size by Application
6.5.3.1 Middle East & Africa Mammalian CDMO Service Market Size by Application (2020-2025)
6.5.3.2 Middle East & Africa Mammalian CDMO Service Market Share by Application (2020-2025)
6.5.4 Middle East & Africa Market Trend and Opportunities
7 Key Players Profiles
7.1 Cytovance Biologics
7.1.1 Cytovance Biologics Company Details
7.1.2 Cytovance Biologics Business Overview
7.1.3 Cytovance Biologics Mammalian CDMO Service Introduction
7.1.4 Cytovance Biologics Revenue in Mammalian CDMO Service Business (2020-2025)
7.1.5 Cytovance Biologics Recent Development
7.2 3P Bio
7.2.1 3P Bio Company Details
7.2.2 3P Bio Business Overview
7.2.3 3P Bio Mammalian CDMO Service Introduction
7.2.4 3P Bio Revenue in Mammalian CDMO Service Business (2020-2025)
7.2.5 3P Bio Recent Development
7.3 AGC Biologics
7.3.1 AGC Biologics Company Details
7.3.2 AGC Biologics Business Overview
7.3.3 AGC Biologics Mammalian CDMO Service Introduction
7.3.4 AGC Biologics Revenue in Mammalian CDMO Service Business (2020-2025)
7.3.5 AGC Biologics Recent Development
7.4 KBI Biopharma
7.4.1 KBI Biopharma Company Details
7.4.2 KBI Biopharma Business Overview
7.4.3 KBI Biopharma Mammalian CDMO Service Introduction
7.4.4 KBI Biopharma Revenue in Mammalian CDMO Service Business (2020-2025)
7.4.5 KBI Biopharma Recent Development
7.5 GTP Bioways
7.5.1 GTP Bioways Company Details
7.5.2 GTP Bioways Business Overview
7.5.3 GTP Bioways Mammalian CDMO Service Introduction
7.5.4 GTP Bioways Revenue in Mammalian CDMO Service Business (2020-2025)
7.5.5 GTP Bioways Recent Development
7.6 Tanvex CDMO
7.6.1 Tanvex CDMO Company Details
7.6.2 Tanvex CDMO Business Overview
7.6.3 Tanvex CDMO Mammalian CDMO Service Introduction
7.6.4 Tanvex CDMO Revenue in Mammalian CDMO Service Business (2020-2025)
7.6.5 Tanvex CDMO Recent Development
7.7 Samsung Biologics
7.7.1 Samsung Biologics Company Details
7.7.2 Samsung Biologics Business Overview
7.7.3 Samsung Biologics Mammalian CDMO Service Introduction
7.7.4 Samsung Biologics Revenue in Mammalian CDMO Service Business (2020-2025)
7.7.5 Samsung Biologics Recent Development
7.8 WuXi Biologics
7.8.1 WuXi Biologics Company Details
7.8.2 WuXi Biologics Business Overview
7.8.3 WuXi Biologics Mammalian CDMO Service Introduction
7.8.4 WuXi Biologics Revenue in Mammalian CDMO Service Business (2020-2025)
7.8.5 WuXi Biologics Recent Development
7.9 PlantForm Corporation
7.9.1 PlantForm Corporation Company Details
7.9.2 PlantForm Corporation Business Overview
7.9.3 PlantForm Corporation Mammalian CDMO Service Introduction
7.9.4 PlantForm Corporation Revenue in Mammalian CDMO Service Business (2020-2025)
7.9.5 PlantForm Corporation Recent Development
7.10 Gedeon Richter
7.10.1 Gedeon Richter Company Details
7.10.2 Gedeon Richter Business Overview
7.10.3 Gedeon Richter Mammalian CDMO Service Introduction
7.10.4 Gedeon Richter Revenue in Mammalian CDMO Service Business (2020-2025)
7.10.5 Gedeon Richter Recent Development
7.11 Lonza
7.11.1 Lonza Company Details
7.11.2 Lonza Business Overview
7.11.3 Lonza Mammalian CDMO Service Introduction
7.11.4 Lonza Revenue in Mammalian CDMO Service Business (2020-2025)
7.11.5 Lonza Recent Development
7.12 Novartis
7.12.1 Novartis Company Details
7.12.2 Novartis Business Overview
7.12.3 Novartis Mammalian CDMO Service Introduction
7.12.4 Novartis Revenue in Mammalian CDMO Service Business (2020-2025)
7.12.5 Novartis Recent Development
7.13 Rentschler Biopharma SE
7.13.1 Rentschler Biopharma SE Company Details
7.13.2 Rentschler Biopharma SE Business Overview
7.13.3 Rentschler Biopharma SE Mammalian CDMO Service Introduction
7.13.4 Rentschler Biopharma SE Revenue in Mammalian CDMO Service Business (2020-2025)
7.13.5 Rentschler Biopharma SE Recent Development
7.14 Northway Biotech
7.14.1 Northway Biotech Company Details
7.14.2 Northway Biotech Business Overview
7.14.3 Northway Biotech Mammalian CDMO Service Introduction
7.14.4 Northway Biotech Revenue in Mammalian CDMO Service Business (2020-2025)
7.14.5 Northway Biotech Recent Development
7.15 Boehringer Ingelheim
7.15.1 Boehringer Ingelheim Company Details
7.15.2 Boehringer Ingelheim Business Overview
7.15.3 Boehringer Ingelheim Mammalian CDMO Service Introduction
7.15.4 Boehringer Ingelheim Revenue in Mammalian CDMO Service Business (2020-2025)
7.15.5 Boehringer Ingelheim Recent Development
7.16 Cambrex
7.16.1 Cambrex Company Details
7.16.2 Cambrex Business Overview
7.16.3 Cambrex Mammalian CDMO Service Introduction
7.16.4 Cambrex Revenue in Mammalian CDMO Service Business (2020-2025)
7.16.5 Cambrex Recent Development
7.17 FUJIFILM Diosynth Biotechnologies
7.17.1 FUJIFILM Diosynth Biotechnologies Company Details
7.17.2 FUJIFILM Diosynth Biotechnologies Business Overview
7.17.3 FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Introduction
7.17.4 FUJIFILM Diosynth Biotechnologies Revenue in Mammalian CDMO Service Business (2020-2025)
7.17.5 FUJIFILM Diosynth Biotechnologies Recent Development
7.18 GBI
7.18.1 GBI Company Details
7.18.2 GBI Business Overview
7.18.3 GBI Mammalian CDMO Service Introduction
7.18.4 GBI Revenue in Mammalian CDMO Service Business (2020-2025)
7.18.5 GBI Recent Development
7.19 Scorpius BioManufacturing
7.19.1 Scorpius BioManufacturing Company Details
7.19.2 Scorpius BioManufacturing Business Overview
7.19.3 Scorpius BioManufacturing Mammalian CDMO Service Introduction
7.19.4 Scorpius BioManufacturing Revenue in Mammalian CDMO Service Business (2020-2025)
7.19.5 Scorpius BioManufacturing Recent Development
8 Mammalian CDMO Service Market Dynamics
8.1 Mammalian CDMO Service Industry Trends
8.2 Mammalian CDMO Service Market Drivers
8.3 Mammalian CDMO Service Market Challenges
8.4 Mammalian CDMO Service Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Mammalian CDMO Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Mammalian CDMO Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Mammalian CDMO Service Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Mammalian CDMO Service Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Mammalian CDMO Service Revenue Share by Region (2020-2025)
Table 6. Global Mammalian CDMO Service Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Mammalian CDMO Service Revenue Share Forecast by Region (2026-2031)
Table 8. Global Mammalian CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Mammalian CDMO Service Revenue Market Share by Type (2020-2025)
Table 10. Global Mammalian CDMO Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Mammalian CDMO Service Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Mammalian CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Mammalian CDMO Service Revenue Market Share by Application (2020-2025)
Table 15. Global Mammalian CDMO Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Mammalian CDMO Service Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Mammalian CDMO Service Application
Table 18. Global Mammalian CDMO Service Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Mammalian CDMO Service Market Share by Players (2020-2025)
Table 20. Global Top Mammalian CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian CDMO Service as of 2024)
Table 21. Ranking of Global Top Mammalian CDMO Service Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Mammalian CDMO Service Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Mammalian CDMO Service, Headquarters and Area Served
Table 24. Global Key Players of Mammalian CDMO Service, Product and Application
Table 25. Global Key Players of Mammalian CDMO Service, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Mammalian CDMO Service Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Mammalian CDMO Service Revenue Market Share by Company (2020-2025)
Table 29. North America Mammalian CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Mammalian CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Mammalian CDMO Service Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Mammalian CDMO Service Revenue Market Share by Company (2020-2025)
Table 33. Europe Mammalian CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Mammalian CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 35. Asia-Pacific Mammalian CDMO Service Revenue by Company (2020-2025) & (US$ Million)
Table 36. Asia-Pacific Mammalian CDMO Service Revenue Market Share by Company (2020-2025)
Table 37. Asia-Pacific Mammalian CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 38. Asia-Pacific Mammalian CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 39. Latin America Mammalian CDMO Service Revenue by Company (2020-2025) & (US$ Million)
Table 40. Latin America Mammalian CDMO Service Revenue Market Share by Company (2020-2025)
Table 41. Latin America Mammalian CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 42. Latin America Mammalian CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 43. Middle East & Africa Mammalian CDMO Service Revenue by Company (2020-2025) & (US$ Million)
Table 44. Middle East & Africa Mammalian CDMO Service Revenue Market Share by Company (2020-2025)
Table 45. Middle East & Africa Mammalian CDMO Service Market Size by Type (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Mammalian CDMO Service Market Size by Application (2020-2025) & (US$ Million)
Table 47. Cytovance Biologics Company Details
Table 48. Cytovance Biologics Business Overview
Table 49. Cytovance Biologics Mammalian CDMO Service Product
Table 50. Cytovance Biologics Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 51. Cytovance Biologics Recent Development
Table 52. 3P Bio Company Details
Table 53. 3P Bio Business Overview
Table 54. 3P Bio Mammalian CDMO Service Product
Table 55. 3P Bio Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 56. 3P Bio Recent Development
Table 57. AGC Biologics Company Details
Table 58. AGC Biologics Business Overview
Table 59. AGC Biologics Mammalian CDMO Service Product
Table 60. AGC Biologics Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 61. AGC Biologics Recent Development
Table 62. KBI Biopharma Company Details
Table 63. KBI Biopharma Business Overview
Table 64. KBI Biopharma Mammalian CDMO Service Product
Table 65. KBI Biopharma Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 66. KBI Biopharma Recent Development
Table 67. GTP Bioways Company Details
Table 68. GTP Bioways Business Overview
Table 69. GTP Bioways Mammalian CDMO Service Product
Table 70. GTP Bioways Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 71. GTP Bioways Recent Development
Table 72. Tanvex CDMO Company Details
Table 73. Tanvex CDMO Business Overview
Table 74. Tanvex CDMO Mammalian CDMO Service Product
Table 75. Tanvex CDMO Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 76. Tanvex CDMO Recent Development
Table 77. Samsung Biologics Company Details
Table 78. Samsung Biologics Business Overview
Table 79. Samsung Biologics Mammalian CDMO Service Product
Table 80. Samsung Biologics Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 81. Samsung Biologics Recent Development
Table 82. WuXi Biologics Company Details
Table 83. WuXi Biologics Business Overview
Table 84. WuXi Biologics Mammalian CDMO Service Product
Table 85. WuXi Biologics Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 86. WuXi Biologics Recent Development
Table 87. PlantForm Corporation Company Details
Table 88. PlantForm Corporation Business Overview
Table 89. PlantForm Corporation Mammalian CDMO Service Product
Table 90. PlantForm Corporation Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 91. PlantForm Corporation Recent Development
Table 92. Gedeon Richter Company Details
Table 93. Gedeon Richter Business Overview
Table 94. Gedeon Richter Mammalian CDMO Service Product
Table 95. Gedeon Richter Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 96. Gedeon Richter Recent Development
Table 97. Lonza Company Details
Table 98. Lonza Business Overview
Table 99. Lonza Mammalian CDMO Service Product
Table 100. Lonza Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 101. Lonza Recent Development
Table 102. Novartis Company Details
Table 103. Novartis Business Overview
Table 104. Novartis Mammalian CDMO Service Product
Table 105. Novartis Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 106. Novartis Recent Development
Table 107. Rentschler Biopharma SE Company Details
Table 108. Rentschler Biopharma SE Business Overview
Table 109. Rentschler Biopharma SE Mammalian CDMO Service Product
Table 110. Rentschler Biopharma SE Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 111. Rentschler Biopharma SE Recent Development
Table 112. Northway Biotech Company Details
Table 113. Northway Biotech Business Overview
Table 114. Northway Biotech Mammalian CDMO Service Product
Table 115. Northway Biotech Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 116. Northway Biotech Recent Development
Table 117. Boehringer Ingelheim Company Details
Table 118. Boehringer Ingelheim Business Overview
Table 119. Boehringer Ingelheim Mammalian CDMO Service Product
Table 120. Boehringer Ingelheim Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 121. Boehringer Ingelheim Recent Development
Table 122. Cambrex Company Details
Table 123. Cambrex Business Overview
Table 124. Cambrex Mammalian CDMO Service Product
Table 125. Cambrex Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 126. Cambrex Recent Development
Table 127. FUJIFILM Diosynth Biotechnologies Company Details
Table 128. FUJIFILM Diosynth Biotechnologies Business Overview
Table 129. FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Product
Table 130. FUJIFILM Diosynth Biotechnologies Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 131. FUJIFILM Diosynth Biotechnologies Recent Development
Table 132. GBI Company Details
Table 133. GBI Business Overview
Table 134. GBI Mammalian CDMO Service Product
Table 135. GBI Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 136. GBI Recent Development
Table 137. Scorpius BioManufacturing Company Details
Table 138. Scorpius BioManufacturing Business Overview
Table 139. Scorpius BioManufacturing Mammalian CDMO Service Product
Table 140. Scorpius BioManufacturing Revenue in Mammalian CDMO Service Business (2020-2025) & (US$ Million)
Table 141. Scorpius BioManufacturing Recent Development
Table 142. Mammalian CDMO Service Market Trends
Table 143. Mammalian CDMO Service Market Drivers
Table 144. Mammalian CDMO Service Market Challenges
Table 145. Mammalian CDMO Service Market Restraints
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Mammalian CDMO Service Product Picture
Figure 2. Global Mammalian CDMO Service Market Share by Type: 2024 VS 2031
Figure 3. Cell Line Development Features
Figure 4. Genomic Analysis Features
Figure 5. Process Development Features
Figure 6. Analytical Services Features
Figure 7. Formulation Development Features
Figure 8. Manufacturing Features
Figure 9. Others Features
Figure 10. Global Mammalian CDMO Service Market Share by Application: 2024 VS 2031
Figure 11. Contract Research Organizations (CROs)
Figure 12. Pharmaceutical
Figure 13. Biotechnology Companies
Figure 14. Government Agencies
Figure 15. Others
Figure 16. Mammalian CDMO Service Report Years Considered
Figure 17. Global Mammalian CDMO Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Mammalian CDMO Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Mammalian CDMO Service Revenue Market Share by Region: 2020 VS 2024
Figure 20. North America Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Europe Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Asia-Pacific Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 23. Latin America Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. Middle East & Africa Mammalian CDMO Service Revenue (US$ Million) Growth Rate (2020-2031)
Figure 25. Global Mammalian CDMO Service Market Share by Players in 2024
Figure 26. Global Top Mammalian CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mammalian CDMO Service as of 2024)
Figure 27. The Top 10 and 5 Players Market Share by Mammalian CDMO Service Revenue in 2024
Figure 28. North America Mammalian CDMO Service Market Share by Type (2020-2025)
Figure 29. North America Mammalian CDMO Service Market Share by Application (2020-2025)
Figure 30. Europe Mammalian CDMO Service Market Share by Type (2020-2025)
Figure 31. Europe Mammalian CDMO Service Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Mammalian CDMO Service Market Share by Type (2020-2025)
Figure 33. Asia-Pacific Mammalian CDMO Service Market Share by Application (2020-2025)
Figure 34. Latin America Mammalian CDMO Service Market Share by Type (2020-2025)
Figure 35. Latin America Mammalian CDMO Service Market Share by Application (2020-2025)
Figure 36. Middle East & Africa Mammalian CDMO Service Market Share by Type (2020-2025)
Figure 37. Middle East & Africa Mammalian CDMO Service Market Share by Application (2020-2025)
Figure 38. Cytovance Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 39. 3P Bio Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 40. AGC Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 41. KBI Biopharma Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 42. GTP Bioways Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 43. Tanvex CDMO Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 44. Samsung Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 45. WuXi Biologics Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 46. PlantForm Corporation Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 47. Gedeon Richter Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 48. Lonza Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 49. Novartis Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 50. Rentschler Biopharma SE Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 51. Northway Biotech Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 52. Boehringer Ingelheim Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 53. Cambrex Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 54. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 55. GBI Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 56. Scorpius BioManufacturing Revenue Growth Rate in Mammalian CDMO Service Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Mammalian CDMO Service market?
The top companies in the global Mammalian CDMO Service market are Cytovance Biologics、3P Bio、AGC Biologics.
Related Reports
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mammalian CDMO Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 148
USD 4900.00
(Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mammalian CDMO Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 105
USD 4250.00
(Single User License)
Mammalian CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 133
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Research Report 2026
The global Mammalian CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-16
Pages: 122
USD 2900.00
(Single User License)
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 124
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Research Report 2025
The global market for Mammalian CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 97
USD 2900.00
(Single User License)
Global Mammalian CDMO Service Market Insights, Forecast to 2030
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-04-10
Pages: 154
USD 4900.00
(Single User License)
Global and United States Mammalian CDMO Service Market Report & Forecast 2024-2030
The global Mammalian CDMO Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-04-10
Pages: 126
USD 4350.00
(Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-04-10
Pages: 124
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mammalian CDMO Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 148
USD 4900.00 (Single User License)Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mammalian CDMO Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 105
USD 4250.00 (Single User License)Mammalian CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 133
USD 3950.00 (Single User License)Global Mammalian CDMO Service Market Research Report 2026
The global Mammalian CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-16
Pages: 122
USD 2900.00 (Single User License)Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 158
USD 4900.00 (Single User License)Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 124
USD 3950.00 (Single User License)Global Mammalian CDMO Service Market Research Report 2025
The global market for Mammalian CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 97
USD 2900.00 (Single User License)Global Mammalian CDMO Service Market Insights, Forecast to 2030
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-04-10
Pages: 154
USD 4900.00 (Single User License)Global and United States Mammalian CDMO Service Market Report & Forecast 2024-2030
The global Mammalian CDMO Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-04-10
Pages: 126
USD 4350.00 (Single User License)Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-10
Pages: 124
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4250.00
USD 6375.00
USD 8500.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now